AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update
about
Beta-blockers for preventing stroke recurrenceBeta-blockers for preventing stroke recurrenceThe clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423].Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature ReviewDrug therapy for prevention of recurrent myocardial infarctionDevelopment and first assessment of a questionnaire for health care utilization and costs for cardiac patientsNeighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance.Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trialAttenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice.Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.Risk factors and in-hospital outcome of acute ST segment elevation myocardial infarction in young Bangladeshi adults.Recent advances in the secondary prevention of coronary heart disease.Assessment of compliance with lipid guidelines in an academic medical center.Practical ways to deal with the high burden of cardiovascular disease in hemodialysis patients.Frequency of undiagnosed and untreated diabetes mellitus in patients with acute coronary syndromes.Optimal medical management of peripheral arterial disease.Non-invasive cardiac assessment in high risk patients (The GROUND study): rationale, objectives and design of a multi-center randomized controlled clinical trialAntiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study.Number of teeth and myocardial infarction and stroke among elderly never smokersEffect of dementia on the use of drugs for secondary prevention of ischemic heart disease.The Sasang constitutional types can act as a risk factor for hypertension.Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.Metabolomics and ischaemic heart disease.The mechanisms of air pollution and particulate matter in cardiovascular diseases.Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.Assessing the clinical utility of biomarkers in medicine.Primary care equals secondary prevention in ischemic heart disease.Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study.Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.Contemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005.Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index.Moderate-carbohydrate low-fat versus low-carbohydrate high-fat meal replacements for weight loss.European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituteEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constitutedOptimism and life satisfaction as determinants for dental and general health behavior-oral health habits linked to cardiovascular risk factors.Effects of 12-week oral supplementation of Ecklonia cava polyphenols on anthropometric and blood lipid parameters in overweight Korean individuals: a double-blind randomized clinical trial.Are recent statin recommendations to employ fixed doses and abandon targets effective for treatment of hypercholesterolaemia? Investigation based on number needed to treat.Increasing physical exercise levels: age-specific benefits of planning.
P2860
Q24193102-4E042CA4-9F30-4521-91CC-F59461FF7026Q24202904-D21CA864-2F5C-44C2-B3E9-A1250B17AA6FQ24816629-4D38385E-B1F7-4F7E-A0EA-D029B7EBC6F1Q28073813-A66A1A0B-F1D3-46F2-B016-E0D05B0EFF77Q28165520-DF83DC59-96CA-41B5-9A25-0FEC62293C67Q33370675-6865B064-C564-454A-A369-1E6D5AFC50C5Q33724790-CD149337-6F80-45C7-9F5F-CB577CBEE161Q34114513-A9BD5E66-F427-4E3B-BABD-054667F5B8FEQ34530216-68DD1CFA-207D-47E5-A6EF-57F8FFCD7A08Q34742666-14DC9A68-E423-4A24-B05C-9DEFA8875F02Q35703843-EC74130A-5EB7-4113-AA05-D6155E8498C2Q35925701-E8B43E48-6D76-48A0-911C-034C0F24A98EQ36341258-E3FD868A-5BB2-43E2-BE5D-D3F2124F4FA7Q36448347-287B5772-1D91-4676-84C9-91B3C4075788Q36569776-F5197CD4-D2CA-417D-9E9D-1D5E5B2D723BQ36588669-F9F1981B-6659-4565-9A7D-BB5F82207BE0Q36844204-FDF3CB55-EBB8-4984-B09C-EEE49ECBD815Q37070041-A7CE5762-26DF-4E0E-A473-6ED72F351AD5Q37175067-13BC1943-C7F6-45DB-A949-EF0234DABDBBQ37639747-F448ADED-1235-4EE8-B8CC-874FA74C2EABQ37940638-B871E17B-348D-432B-BBAC-8E2BFE32532BQ38007395-D7E2C1FE-A91A-4D2A-A9EC-F21F64F8B4A8Q38060209-A6807230-D982-4B95-94C5-8E61ABD73255Q39183181-7317F97D-7DDC-4CF8-B8C8-8BCECB66E9C1Q39281747-E1CC72EA-F923-48EB-8061-2BC2A1C01922Q39482145-CEA6177F-C807-4135-B38C-8A93870B717CQ40169397-62153A3A-9CF9-4FD6-9EB4-17CCA11874C2Q42923394-803EA065-6976-46C5-89DA-5F30A81F1684Q43225362-FECD7E99-B1F3-4C3C-A29D-79FBCCBF6941Q43279433-71FC3050-4FAD-49B5-8A7C-D9D76AC6E9DEQ43286812-72BBAA08-6E11-4203-BD70-CAF7F4A6C7FAQ45365181-18291D2E-D2BC-49E6-99A5-9F470CC13B44Q47230930-59BA336A-24E4-4E78-BE9B-2FF341E0E358Q47283846-309DE502-6688-4E51-9657-E5E01A85FE8DQ48525600-1C932A3B-C334-421F-BDB3-F6962629FE97Q48526535-3ABB3CF5-15D2-4B3B-93AA-18640293294EQ51030037-096CD986-6AEA-4268-AA0E-F78612A27B97Q51443809-4EEE1D5D-7053-43F1-8F21-274AE9B44776Q51817830-19FB0DF5-0A31-4CAE-808A-BE19D3B37175Q51899657-4069EB1C-C6B1-46D8-A5D2-3D655E5B23D4
P2860
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update
description
article
@en
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2001
@uk
name
AHA/ACC Guidelines for Prevent ...... ovascular Disease: 2001 Update
@en
AHA/ACC Guidelines for Prevent ...... ovascular Disease: 2001 Update
@nl
type
label
AHA/ACC Guidelines for Prevent ...... ovascular Disease: 2001 Update
@en
AHA/ACC Guidelines for Prevent ...... ovascular Disease: 2001 Update
@nl
prefLabel
AHA/ACC Guidelines for Prevent ...... ovascular Disease: 2001 Update
@en
AHA/ACC Guidelines for Prevent ...... ovascular Disease: 2001 Update
@nl
P2093
P921
P356
P1433
P1476
AHA/ACC Scientific Statement: ...... American College of Cardiology
@en
P2093
Cerqueira MD
P304
P356
10.1161/HC3801.097475
P407
P577
2001-09-01T00:00:00Z